A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

NCT00363714 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Macular Degeneration
Choroidal Neovascularization

Interventions

DRUG: AGN211745
DRUG: AGN211745
DRUG: AGN211745
DRUG: AGN211745
DRUG: AGN211745
DRUG: AGN211745

Sponsor

Allergan

Collaborators

[object Object]